Abstract
Between 1974 and 1984 69 adults with acute lymphoblastic leukaemia (ALL) were treated with two different protocols. Fifty-four (78%) of the patients entered complete remission (CR); 27 of these then received a consolidation protocol consisting of daunorubicin, cytosine arabinoside and 6-thioguanine, followed by two courses of intravenous methotrexate 500 mg m-2 with folinic acid rescue. All patients received intrathecal methotrexate and cranial irradiation (24 Gy) followed by maintenance therapy with 6-mercaptopurine and methotrexate for at least 2 years. The median survival for all patients was 23 months from the time of presentation with an actuarial 5-year survival of 21%. The actuarial chance of surviving 5 years in CR for patients receiving the consolidation protocol was 38% compared to 19% for patients receiving no consolidation (P = NS). Only patient age and white cell count at presentation were found to influence the chance of achieving CR and the chance of overall survival. The presence or absence of c-ALL antigen did not influence prognosis. Patients younger than 35 years with low white cell counts at presentation (less than 10 X 10(9)1(-1] had a particularly good prognosis but no patient with T-ALL and no patient older than 50 years old at diagnosis survived more than 18 months.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Marcus, R., Catovsky, D., Johnson, S. et al. Adult acute lymphoblastic leukaemia: A study of prognostic features and response to treatment over a ten year period. Br J Cancer 53, 175–180 (1986). https://doi.org/10.1038/bjc.1986.32
Issue Date:
DOI: https://doi.org/10.1038/bjc.1986.32
This article is cited by
-
Acute lymphoblastic leukemia in patients over 59 years of age
Annals of Hematology (1994)
-
Acute lymphoblastic leukaemia in adults: Immunological subtypes and clinical features at presentation
Annals of Hematology (1993)
-
Prognostic significance of general immune competence in acute leukemia
Medical Oncology and Tumor Pharmacotherapy (1990)